Steward Partners Investment Advisory, LLC Harrow Health, Inc. Transaction History
Steward Partners Investment Advisory, LLC
- $9.37 Billion
- Q2 2024
A detailed history of Steward Partners Investment Advisory, LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 86,625 shares of HROW stock, worth $3.77 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
86,625
Previous 64,334
34.65%
Holding current value
$3.77 Million
Previous $851,000
112.57%
% of portfolio
0.02%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding HROW
# of Institutions
121Shares Held
19.7MCall Options Held
700KPut Options Held
575K-
Opaleye Management Inc. Boston, MA3.99MShares$174 Million21.35% of portfolio
-
Private Capital Management, LLC Naples, FL2.71MShares$118 Million7.1% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$93.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.84MShares$80.2 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA719KShares$31.3 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $1.18B
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...